• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

In recent years, it has become apparent that coronary microvascular dysfunction plays a
pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect …

This consensus document, a summary of the views of an expert panel organized by the
European Association of Percutaneous Cardiovascular Interventions (EAPCI), appraises the …

In 2008, the Guidelines for diagnosis and treatment of patients with vasospastic angina
(coronary spastic angina) 1 were developed by the Japanese Circulation Society, and the …

This consensus document, a summary of the views of an expert panel organized by the
European Association of Percutaneous Cardiovascular Interventions (EAPCI), appraises the …

Objectives: This study sought to assess the performance of cardiovascular magnetic
resonance (CMR) myocardial perfusion mapping against invasive coronary physiology …

Ischemic heart disease secondary to coronary vascular dysfunction causes angina and
impairs quality of life and prognosis. About one-half of patients with symptoms and signs of …

Background: Determine the prevalence and correlates of microvascular and vasospastic
angina in patients with symptoms and signs of ischemia but no obstructive coronary artery …

Ischemic heart disease (IHD) is the leading cause of mortality in women. While traditional
cardiovascular risk factors play an important role in the development of IHD in women …

Background: A bolus thermodilution-derived index of microcirculatory resistance (IMR) has
emerged as the standard for assessing coronary microvascular dysfunction (CMD) …